Nortec Quimica SA
⚠️ Moderate Risk
FEI: 3007616930 • Duque De Caxias, Rio de Janeiro • BRAZIL
FEI Number
3007616930
Location
Duque De Caxias, Rio de Janeiro
Country
BRAZILAddress
Rua Dezessete # 200, Dist. Ind. Duque De Caxias - Xerem, Duque De Caxias, Rio de Janeiro, Brazil
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
Frequently Asked Questions
What is Nortec Quimica SA's FDA import refusal history?
Nortec Quimica SA (FEI: 3007616930) has 2 FDA import refusal record(s) in our database, spanning from 5/17/2011 to 6/22/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Nortec Quimica SA's FEI number is 3007616930.
What types of violations has Nortec Quimica SA received?
Nortec Quimica SA has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Nortec Quimica SA come from?
All FDA import refusal data for Nortec Quimica SA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.